News
-
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: No vote on items 7 and 8 of the agenda at the Annual Shareholders’ Meeting on May 8, 2026 - Cancellation of the separate meeting of preferred shareholders
Drägerwerk AG & Co. KGaA removes items 7 and 8 from Annual Shareholders’ Meeting agenda on May 8, 2026. Separate meeting of preferred shareholders canceled -
-
-
-
PRESS RELEASE
EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Drägerwerk AG & Co. KGaA reports Q1 2026 preliminary results: strong earnings growth, net sales increase, and positive EBIT margin. Forecast for 2026 includes higher sales and EBIT margin -
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Drägerwerk AG & Co. KGaA reports significant earnings growth in Q1 2026, with net sales up by 6.9%. Positive trends in both medical and safety divisions drive increase in EBIT and order intake -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Dräger with good order development, record net sales and significant increase in net profit in fiscal year 2025 – third dividend increase in a row
Drägerwerk AG & Co. KGaA reports record net sales and significant profit increase for fiscal year 2025, along with a third consecutive dividend hike
